In the pan-European dispute over Soliris, Alexion has now suffered another defeat. The UK High Court found that an important patent relating to the active ingredient eculizumab would have to be
sales in other countries, and there are no lawsuits against Sunwoda elsewhere. In Germany, Sunwoda filed nullity actions against EP 139 and EP 141. The Federal Patent Court’s preliminary opinion deemed
According to an order of the Düsseldorf local division, the parties have now settled (case ID: UPC_CFI_504/2023). The details of the settlement are not known. However, according to JUVE Patent sources
A long-running dispute between Fresenius Medical Care and Nipro over dialysis technology has concluded in Germany. The Federal Court of Justice declared the patent-in-suit invalid, thereby removing
at the Mannheim local division concerns EP 2 028 981, the patent-in-suit at the Paris local division is EP 3 155 936. Both relate to a juice extractor. In March, the Mannheim division found that NUC
EPO, and an infringement suit was dismissed by Munich Regional Court. Today, the Mannheim local division also dismissed the infringement suit relating to the second patent. Dish accuses Aylo of
The global patent dispute between Nokia and Amazon has ended. Today, the Finnish tech company announced it had signed an agreement with the US company covering the use of Nokia's video technologies
argued there was a risk of imminent infringement of its patent EP 1 830 843 B1, which protects the use of nintedanib or nintedanib esylate, from 12 December 2024. The pharma company also owns the related
The settlement had been hinted at in recent days after signs emerged in the US and at the UPC that hearings were no longer taking place. JUVE Patent learned from lawyers involved in the case that the
and demanded a PI, it filed an action for infringement of EP 533, EP 986, EP 066 and GB patent 2 510 725 at the UK High Court (case ID: HP-2025-000037). Guardant is seeking a permanent injunction